These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25324787)

  • 1. Alcohol and Relatively Pure Cannabis Use, but Not Schizotypy, are Associated with Cognitive Attenuations.
    Herzig DA; Nutt DJ; Mohr C
    Front Psychiatry; 2014; 5():133. PubMed ID: 25324787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemispheric language asymmetry in first episode psychosis and schizotypy: the role of cannabis consumption and cognitive disorganization.
    Herzig DA; Sullivan S; Lewis G; Corcoran R; Drake R; Evans J; Nutt D; Mohr C
    Schizophr Bull; 2015 Mar; 41 Suppl 2(Suppl 2):S455-64. PubMed ID: 25543118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inferring about individual drug and schizotypy effects on cognitive functioning in polydrug using mephedrone users before and after clubbing.
    Herzig DA; Brooks R; Mohr C
    Hum Psychopharmacol; 2013 Mar; 28(2):168-82. PubMed ID: 23532749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users.
    Cohen K; Rosenzweig S; Rosca P; Pinhasov A; Weizman A; Weinstein A
    Front Psychiatry; 2020; 11():355. PubMed ID: 32477173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polydrug use, cannabis, and psychosis-like symptoms.
    Van Dam NT; Earleywine M; DiGiacomo G
    Hum Psychopharmacol; 2008 Aug; 23(6):475-85. PubMed ID: 18449850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis users differ from non-users on measures of personality and schizotypy.
    Fridberg DJ; Vollmer JM; O'Donnell BF; Skosnik PD
    Psychiatry Res; 2011 Mar; 186(1):46-52. PubMed ID: 20813412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of schizotypy among cannabis and alcohol users.
    Nunn JA; Rizza F; Peters ER
    J Nerv Ment Dis; 2001 Nov; 189(11):741-8. PubMed ID: 11758656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction between the ZNF804A gene and cannabis use on the risk of psychosis in a non-clinical sample.
    Soler J; Arias B; Moya J; Ibáñez MI; Ortet G; Fañanás L; Fatjó-Vilas M
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():174-180. PubMed ID: 30118824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizotypy and clinical symptoms, cognitive function, and quality of life in individuals with a psychotic disorder.
    Brosey E; Woodward ND
    Schizophr Res; 2015 Aug; 166(1-3):92-7. PubMed ID: 26002072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis.
    Colizzi M; Iyegbe C; Powell J; Ursini G; Porcelli A; Bonvino A; Taurisano P; Romano R; Masellis R; Blasi G; Morgan C; Aitchison K; Mondelli V; Luzi S; Kolliakou A; David A; Murray RM; Bertolino A; Di Forti M
    Schizophr Bull; 2015 Sep; 41(5):1171-82. PubMed ID: 25829376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.
    D'Souza DC; Ganesh S; Cortes-Briones J; Campbell MH; Emmanuel MK
    Psychol Med; 2020 Oct; 50(14):2452-2459. PubMed ID: 31615592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizotypy but not Cannabis Use Modestly Predicts Psychotogenic Experiences: A Cross-Sectional Study Using the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE).
    Airey ND; Hammersley R; Reid M
    J Addict; 2020; 2020():5961275. PubMed ID: 33123406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample.
    Barkus E; Lewis S
    Psychol Med; 2008 Sep; 38(9):1267-76. PubMed ID: 18205966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizotypy and nicotine, alcohol, and cannabis use in a non-psychiatric sample.
    Esterberg ML; Goulding SM; McClure-Tone EB; Compton MT
    Addict Behav; 2009 Apr; 34(4):374-9. PubMed ID: 19136217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the interaction between schizotypy, divergent thinking and cannabis use.
    Schafer G; Feilding A; Morgan CJ; Agathangelou M; Freeman TP; Valerie Curran H
    Conscious Cogn; 2012 Mar; 21(1):292-8. PubMed ID: 22230356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort.
    Stirling J; Barkus EJ; Nabosi L; Irshad S; Roemer G; Schreudergoidheijt B; Lewis S
    Psychopathology; 2008; 41(6):371-8. PubMed ID: 18787359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between past alcohol, cannabis, and cocaine use and current schizotypy among first-degree relatives of patients with schizophrenia and non-psychiatric controls.
    Compton MT; Chien VH; Bollini AM
    Psychiatr Q; 2009 Sep; 80(3):143-54. PubMed ID: 19396546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis.
    Freeman AM; Mokrysz C; Hindocha C; Lawn W; Morgan CJ; Freeman TP; Saunders R; Curran HV
    J Psychopharmacol; 2021 Jul; 35(7):804-813. PubMed ID: 33427016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cannabis use and schizotypal dimensions--a meta-analysis of cross-sectional studies.
    Szoke A; Galliot AM; Richard JR; Ferchiou A; Baudin G; Leboyer M; Schürhoff F
    Psychiatry Res; 2014 Sep; 219(1):58-66. PubMed ID: 24878296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age moderates the association between frequent cannabis use and negative schizotypy over time.
    Albertella L; Le Pelley ME; Yücel M; Copeland J
    Addict Behav; 2018 Dec; 87():183-189. PubMed ID: 30053703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.